Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study

Other authors

Institut Català de la Salut

[Menéndez-Torre EL] Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain. Grupo ENDO, Instituto de Investigación Biomédica del Principado de Asturias (ISPA), Oviedo, Spain. Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain. [Gutiérrez-Hurtado A] Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain. [Ollero MD, Irigaray A] Department of Endocrinology and Nutrition, Hospital Universitario de Navarra, Pamplona, Spain. [Martín P, Parra P] Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. [Biagetti B] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-07-08T06:24:44Z

2024-07-08T06:24:44Z

2024-06-17



Abstract

Rathke’s cleft cyst; Transsphenoidal surgery; Visual impairment


Quiste de hendidura de Rathke; Hipófisis; Cirugía transesfenoidal


Quist de fendedura de Rathke; Hipòfisi; Cirurgia transesfenoïdal


Rathke’s cleft cysts (RCC) are a common type of lesion found in the sellar or suprasellar area. They are usually monitored clinically, but in some cases, surgery may be required. However, their natural progression is not yet well understood, and the outcomes of surgery are uncertain. The objective of this study is to evaluate the natural history of Rathke’s cleft cysts in patients who are clinically monitored without treatment, and to determine the outcomes of surgery and the incidence of recurrences over time. Design and patients: National multicentric study of patients diagnosed of Rathke’s cleft cyst (RCC- Spain) from 2000 onwards and followed in 15 tertiary centers of Spain. A total of 177 patients diagnosed of RCC followed for 67.3 months (6–215) and 88 patients who underwent surgery, (81 patients underwent immediate surgery after diagnosis and 7 later for subsequent growth) followed for 68.8 months (3–235). Results: The cyst size remained stable or decreased in 73.5% (133) of the patients. Only 44 patients (24.3%) experienced a cyst increase and 9 of them (5.1%) experienced an increase greater than 3 mm. In most of the patients who underwent surgery headaches and visual alterations improved, recurrence was observed in 8 (9.1%) after a median time of 96 months, and no predictors of recurrence were discovered. Conclusions: Rathke’s cleft cysts without initial compressive symptoms have a low probability of growth, so conservative management is recommended. Patients who undergo transsphenoidal surgery experience rapid clinical improvement, and recurrences are infrequent. However, they can occur after a long period of time, although no predictors of recurrence have been identified.

Document Type

Article


Published version

Language

English

Publisher

Frontiers Media

Related items

Frontiers in Endocrinology;15

https://doi.org/10.3389/fendo.2024.1413810

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)